Podcasts about Mayo Clinic

Things are getting wooshy this week — maybe it's Brandi's post-blood-draw haze or Wells' weed drink enlightenment — but either way, YFT is straight-up floatin y'all. Exhibit A: Wells clocked a full nine hours and seventeen minutes of sleep with a resting heart rate low enough to qualify him for a Mayo Clinic newsletter (he swears he's fine). From there, your hosts spin into why billionaires only ever seem to climb Everest or start space programs, why Mallworld might be the greatest shared fever dream of our generation, and why today's kids simply need to go out and party more.Fave things this week include medieval dragons, true hauntings, dancing stars and missing cons, plus some wildly passionate listener voicemails to round it all out. Buckle up, YFT fam — we're wooshin'.Thanks to our awesome sponsors for supporting this episode! Mood: Get 20% off your first order at Mood.com/YFT with promo code YFT.Hungryroot: For a limited time get 40% off your first box PLUS get a free item in every box for life. Go to Hungryroot.com/yft and use code yft.Quince: Treat your closet to a little summer glow-up with Quince. Go to Quince.com/yft for free shipping on your order and 365 day returns.Cowboy Colostrum: For a limited time, our listeners are getting 25% off their entire order. Just head to CowboyColostrum.com and use code YFT at checkout.Fabletics: Treat yourself to gear that looks good, feels good, and doesn't break the bank with Fabletics. Go to Fabletics.com/YFT and sign up as a VIP and get eighty percent off everything.Draft Kings: New players get FIVE HUNDRED SPINS over TEN DAYS on your choice of Cash Eruption slots when you wager five dollars. Get the app, sign up with code YFT, then start spinning on THE Home of Cash Eruption.Skims: Shop my favorite bras and underwear at SKIMS.com. After you place your order, be sure to let them know we sent you! Select "podcast" in the survey and be sure to select our show in the dropdown menu that followsDon't forget to rate, review, and follow Your Favorite Podcast! Plus, keep up with us between episodes on our Instagram pages, @yftpodcast @wellsadams and @brandicyrus and be sure to leave us a voicemail with your fave things at 858-630-1856! This podcast is brought to you by Podcast Nation.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this first part of a two-part episode, host David Mandell welcomes Dr. Jack Bert, a board-certified orthopedic surgeon and former president of the Arthroscopy Association of North America. Dr. Bert shares his background, including his training at Northwestern, Temple, and the Mayo Clinic, as well as his career—building one of the first outpatient ambulatory surgery centers in Minnesota. He highlights how his practice expanded from a solo effort into a large multi-location group, providing insight into the evolution of orthopedic practice models. Dr. Bert reflects on the influences that led him to orthopedics, including his brother, a spine surgeon, and his time training with John Lachman. He emphasizes the role of innovation in orthopedic surgery, from pioneering arthroscopic procedures to developing surgical tools and implants. His experiences underscore the importance of adapting to insurance reimbursement models and industry dynamics that affect medical practice and physician compensation. Beyond his clinical and entrepreneurial achievements, Dr. Bert discusses his involvement with industry partners and his tenure on the board of the Retired NFL Players Association, where he saw firsthand the long-term toll professional football takes on players. He also stresses the importance of ancillary services and delegation for physicians to achieve financial success, drawing parallels between leveraging physician extenders in medicine and delegating financial management to professionals. Learn more, including additional show notes, links, and detailed key takeaways, by visiting physicianswealthpodcast.com. Click here to get your FREE copy of our latest book, Wealth Strategies for Today's Physician!

Rich sits down with coach and recovery advocate Jennifer Chase, whose life spans both sides of addiction—as the daughter of an alcoholic, a woman in long-term recovery, and the mother of a recovering addict. She shares how trauma, chronic pain, and over-prescription pulled her into dependency, and how connection, forgiveness, and firm, loving boundaries rebuilt her family. Listeners will learn practical ways families can stop enabling, set clear limits, and find peace—no matter where their loved one is on the recovery path. Sponsored by Living Well Healthcare Guest Bio:  Jennifer Chase is an addiction and family recovery coach and founder of Rise Addiction Life Coaching. After surviving a hemorrhaging brain tumor, years of chronic pain, and opioid dependency, she rebuilt her life in long-term recovery and now helps families replace chaos with clarity through coaching groups, retreats, and one-to-one guidance. Main Topics: ·         Addiction vs. recovery “circles” and why connection saves lives. ·         Generational trauma: growing up around alcoholism and childhood sexual abuse. ·         Brain tumor at 29, chronic pain, and how over-prescription led to opioid addiction. ·         Discovering her teenage son's opioid use and choosing treatment. ·         Why “substance isn't the problem”—shame, coping, and choosing your hard. ·         Family roles, enabling vs. allowing consequences, and boundary-setting that sticks. ·         Self-care for helpers: meditation, exercise, journaling, therapy, service. ·         Jennifer's services: individual coaching, twice-weekly coaching calls, and retreats.  Resources mentioned: ·         Rise Addiction Life Coaching – www.riseaddictionlc.com (Jennifer's site). ·         Mayo Clinic (treatment exploration referenced). ·         Podcasts/people referenced in passing (e.g., “Mr. Whiskey,” “Tanya”) as cross-guest overlap. ·         Practices: meditation, running/exercise, journaling, massage, yoga/chiropractic, counseling.·         Episode Sponsor: Send us a textLiving Well HealthcareGet Your Lifestyle BackDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showRate & Review on Apple Podcasts Follow the Conversations with Rich Bennett podcast on Social Media:Facebook – Conversations with Rich Bennett Facebook Group (Join the conversation) – Conversations with Rich Bennett podcast group | FacebookTwitter – Conversations with Rich Bennett Instagram – @conversationswithrichbennettTikTok – CWRB (@conversationsrichbennett) | TikTok Sponsors, Affiliates, and ways we pay the bills:Hosted on BuzzsproutSquadCast Subscribe by Email

Today we have Sue. She is 54 years old from Stewartville, MN and she took her last drink of alcohol on May 9th, 2023.   This episode brought to you by:   Sober Link sign up and claim your $100 enrollment bonus   Next Monday, October 20th, we start our four-week mindfulness course in Café RE. It starts at 7:30pm Eastern and we hope to see you there!   [02:36] Thoughts from Paul:   Paul shares that while visiting his parents in Colorado, he lost his wallet at a park. Thankfully, a high school friend's mom ended up being the one that found it. When he picked it up from her, she told him that her son is recently sober and gave Paul his phone number to reconnect.   Paul had recently tried to rejoin the fantasy football league he had previously been a part of and was denied re-entry. This brought up huge feelings of rejection reminiscent of his childhood. While on a retreat with his sober friend in Mexico, Paul found himself dwelling on the negative emotions when he caught himself looking at a beer a fellow diner was having. The thought that “one or two beers would make you feel better” came over him, but then he looked at his newly sober friend and reflected on the great talks of sobriety that they had shared, and the thoughts went away.   Reeling from this, Paul went outside, shook his head a few times and then was filled with a warm embrace by the universe knowing that his lost wallet put him in Mexico with his sober friend and everything ended up alright.   [07:36] Paul introduces Sue:   Sue is 54 years old and has two adult children and one granddaughter. She works as a housekeeper for a hospital at the Mayo Clinic and for fun she loves nature, animals, hikes, jet skiing, kayaking and birdwatching.   Sue's parents were both daily drinkers. Sue would sip her dads beer because she thought it was cool, but her first real drinking experience was when she stole some sloe gin from her parent's pantry at age 13 or 14.   In her teenage years she began to party a lot on the weekends. Sue was a shy girl, and drinking helped her open up and gave her the attention she craved. Her grades in school began to suffer because she was skipping a lot and Sue ended up unable to graduate.   Sue never thought her drinking was a problem even after getting in trouble for underage drinking. Her boyfriend was abusive, but due to her craving for love and attention, Sue kept going back to him. After a long breakup, he returned wanting to reunite, claiming he had changed. Soon Sue became pregnant, got married, quit drinking and focused on having a family.   Sue enjoyed being a mother. Her husband worked a lot, so she did a lot of the parenting on her own while working a full-time job. As the kids got older and were home less, Sue began to drink more. She tried to hide her drinking, but her kids began to notice. Sue and her husband were fighting a lot and eventually had a messy divorce in which her husband got custody, which was very hard on Sue.   Sue got remarried in 2015 and while she cut back a little, her husband started calling her out on how often she was drinking. This led to her hiding her drinking again and several hospitalizations over the next few years.   In 2017, after a hospitalization, Sue was able to get sober with the help of AA. She says complacency led to relapses. Her children had cut her off and there were multiple inpatient and outpatient attempts but nothing stuck until May 9th, 2023.   Sue says the difference this time is that she fully surrendered and is doing this for herself and not others. She checked herself Hazelden and dug into the work of loving herself again. She still stays active with that community and her AA group. Sue says her  spirituality comes from nature and her belief in prayer and hope.  She has been able to reconnect with her children over the past year and has plans to become a peer recovery specialist.   Recovery Elevator Go big, because eventually we all go home. I love you guys.   RE on Instagram Recovery Elevator YouTube Sobriety Tracker iTunes     

Dr. Geoff Dow, CEO of 60 Degrees Pharmaceuticals and former malaria drug developer at Walter Reed, joins the Tick Boot Camp Podcast to unpack the science and strategy behind treating babesiosis. Drawing parallels to malaria, Dow explains why tafenoquine (brand: Arakoda), FDA-approved for malaria prevention, is being studied for Babesia, how coinfections (Borrelia, Bartonella) complicate care, and why chronic illness needs a different clinical approach. He previews an upcoming Mount Sinai trial for chronic babesiosis focused on fatigue outcomes and discusses real-world diagnostics using FDA-approved blood donor screening plus PCRs from Galaxy Diagnostics and Mayo Clinic. The conversation also touches on prophylaxis concepts, immune dysregulation, and building a clearer path from anecdote to evidence for the tick-borne disease community. Guest Geoff Dow, BSc, MBA, PhD CEO & Board Member, 60 Degrees Pharmaceuticals Background: Biotechnology (Perth, Australia), PhD in malaria drug discovery, decade at Walter Reed Army Institute of Research, MBA in the U.S. Leads clinical programs exploring tafenoquine for babesiosis. Key Topics & Takeaways Malaria ↔ Babesiosis Parallels: Both are red-blood-cell parasites; acute symptoms driven by red cell destruction. Similar drug targets justify testing some anti-malarials against Babesia. Why Tafenoquine (Arakoda): An 8-aminoquinoline that induces oxidative stress in RBCs; distinct mechanism from atovaquone + azithromycin combo (current standard for acute babesiosis), potentially useful for resistance management. Chronic vs. Acute Disease: Acute babesiosis in immunocompetent patients often responds to standard care; chronic illness remains under-defined and underserved. Coinfections Are Common: Many chronically ill patients present with Borrelia, Bartonella, and Babesia together; diagnostics and treatment need to acknowledge polymicrobial reality. Upcoming Clinical Trial (Mount Sinai): Population: Chronic babesiosis with disabling fatigue, plus Babesia symptoms (e.g., air hunger, anemia) and lab evidence in the last 12 months. Regimen: 4-day loading dose then 200 mg weekly of tafenoquine for 3 months. Outcomes: Patient-reported fatigue (quality-of-life) + monthly molecular testing (FDA blood donor test, Galaxy Diagnostics PCR, Mayo Clinic PCR) during treatment and 3 months post-therapy. Goals: Demonstrate symptom improvement, assess eradication signals, and validate accessible diagnostics against an FDA-accepted assay. Prophylaxis & Post-Exposure Ideas: Animal data suggest short-course tafenoquine can eradicate early Babesia; human prophylaxis trials face feasibility and regulatory hurdles. Diagnostics Gap: Need for standardized, sensitive tools to define chronic babesiosis and track response. This trial also serves as a real-world diagnostic comparison. Immune Dysregulation & IACI: Overlap among long COVID, ME/CFS, post-treatment Lyme—shared theme of immune dysregulation with possible persistent antigen stimulation. Safety Notes: G6PD deficiency is relevant to 8-aminoquinolines; established safety database exists for malaria prevention dosing—critical as studies expand to babesiosis. Notable Quotes “You've got to put some lines in the sand—run the trial, collect data, and move the field forward.” “The best we can do for chronic disease starts with defining it—and validating the diagnostics we use to track it.” “8-aminoquinolines offer a different mechanism than current babesiosis standards—key for resistance and combinations.” Resources Mentioned Arakoda (tafenoquine): FDA-approved for malaria prevention; under study for babesiosis. Diagnostics: FDA-approved Babesia blood donor screen; Galaxy Diagnostics PCR; Mayo Clinic PCR. Organizations & Events: ILADS, Global Lyme Alliance, tick-borne disease conferences. Research Partners: Mount Sinai (NYC), Tulane University (Bartonella/Borrelia collaboration). Who Should Listen Patients with chronic Lyme or chronic babesiosis symptoms (fatigue, air hunger, anemia) Clinicians seeking updates on Babesia treatment research and diagnostics Caregivers and advocates tracking IACI and immune dysregulation science Researchers exploring antimalarial repurposing for tick-borne diseases Call to Action Subscribe to Tick Boot Camp and share this episode with someone navigating chronic tick-borne illness.

In this episode of the NCS Podcast Perspectives series, Nicholas Morris, MD, is joined by Eelco Wijdicks, MD, PhD, professor of neurology at Mayo Clinic and chair of the Division of Critical Care Neurology. A pioneer of neurocritical care, Dr. Wijdicks reflects on training in Rotterdam, fellowship at Mass General under Allan H. Ropper, MD, and the creation of Mayo Clinic's neuro ICU in the 1990s. Wijdicks shares the story behind the FOUR Score Coma Scale and lessons from subarachnoid hemorrhage, hyponatremia and cerebral salt wasting, including how early fluid-restriction practices shaped outcomes. The conversation also explores building a new specialty, the role of neurologists in the ICU, the history of medicine and “neuro cinema,” as well as compassion fatigue and the future of global neurocritical care. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

Bill George is a celebrated leader who served as Chair and CEO of Medtronic, the world's leading medical technology company. He is an executive fellow at Harvard Business School, where he has taught leadership since 2004, and is the bestselling author of many books, including Discover Your True North. Bill also served as a director at Goldman Sachs, ExxonMobil, Novartis, Target, the Mayo Clinic, and World Economic Forum USA. In this episode of ⁠the Elevate Podcast⁠, Bill joins host Robert Glazer to discuss his leadership career, the importance of purpose-driven leadership, and more. To learn more about core values, check out The Compass Within. Thank you to the sponsors of The Elevate Podcast Mizzen & Main: ⁠⁠mizzenandmain.com⁠⁠ (Promo Code: elevate20) Shopify: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠shopify.com/elevate⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Indeed: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠indeed.com/elevate⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Masterclass: ⁠⁠masterclass.com/elevate⁠⁠ Found: ⁠⁠found.com/elevate Learn more about your ad choices. Visit megaphone.fm/adchoices

Got a show or guest idea? Send us a text!In 1974, doctors at the Mayo Clinic in Rochester, Minnesota, delivered grim news. They scheduled him for chemotherapy and advised him to bring his family to say their goodbyes. But Rick Hill defied the odds—and the conventional path.Rick Hill's story is more than a tale of survival—it's a legacy of hope, determination, and advocacy for transparency and choice in cancer treatment.For those seeking inspiration in the face of adversity, Rick Hill's life proves that even the darkest diagnoses can lead to a brighter future.Use code REMEDY at https://rncstore.comSupport the show

While genetic testing has replaced muscle biopsy in the diagnosis of many genetic myopathies, clinical assessment and the integration of clinical and laboratory findings remain key elements for the diagnosis and treatment of muscle diseases. In this episode, Casey Albin, MD, speaks with Margherita Milone, MD, PhD, FAAN, FANA, author of the article “A Pattern Recognition Approach to Myopathy” in the Continuum® October 2025 Muscle and Neuromuscular Junction Disorders issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Milone is a professor of neurology and the director of the Muscle Pathology Laboratory at Mayo Clinic College of Medicine and Science in Rochester, Minnesota. Additional Resources Read the article: A Pattern Recognition Approach to Myopathy Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Albin: Hello, this is Dr Casey Albin. Today I'm interviewing Dr Margherita Milone on her article on a pattern recognition approach to myopathy, which appears in the October 2025 Continuum issue on muscle and neuromuscular junction disorders. Welcome to the podcast, Dr Milone. Thank you so much for joining us. I'll start off by having you introduce yourself to our listeners. Dr Milone: Hello Casey, thank you so much for this interview and for bringing the attention to the article on muscle diseases. So, I'm Margherita Milone. I'm one of the neuromuscular neurologists at Mayo Clinic in Rochester. I have been interested in muscle disorders since I was a neurology resident many years ago. Muscle diseases are the focus of my clinical practice and research interest. Dr Albin: Wonderful. Thank you so much. When I think about myopathies, I generally tend to think of three large buckets: the genetic myopathy, the inflammatory myopathies, and then the necrotizing myopathies. Is that a reasonable approach to conceptualizing these myopathies? Dr Milone: Yeah, the ideology of the myopathies can be quite broad. And yes, we have a large group of genetic muscle diseases, which are the most common. And then we have immune-mediated muscle diseases, which include inflammatory myopathies as well as some form of necrotizing myopathies. Then we have some metabolic myopathies, which could be acquired or could be genetic. And then there are muscle diseases that are due to toxins as well as to infection. Dr Albin: Wow. So, lots of different etiologies. And that really struck me about your article, is that these can present in really heterogeneous ways, and some of them don't really read the rule book. So, we have to have a really high level of suspicion, for someone who's coming in with weakness, to remember to think about a myopathy. One of the things that I like to do is try to take us through a little bit of a case to sort of walk us through how you would approach if someone comes in. So, let's say you get, you know, a forty-year-old woman, and she's presenting with several months of progressive weakness. And she says that even recently she's noted just a little bit of difficulty swallowing. It feels to her like things are getting stuck. What are some of the things when you are approaching the history that would help you tease this to a myopathy instead of so many other things that can cause a patient to be weak? Dr Milone: Yes. So, as you mentioned, people who have a muscle disease have the muscle weakness often, but the muscle weakness is not just specific for a muscle disease. Because you can have a mass weakness in somebody who has a neurogenic paralysis. The problem with diagnosis of muscle diseases is that patients with these disorders have a limited number of symptom and sign that does not match the large heterogeneity of the etiology. So, in someone who has weakness, that weakness could represent a muscle disease, could represent an anterior horn cell disease, could represent a defect of neuromuscular junction. The clinical history of weakness is not sufficient by itself to make you think about a muscle disease. You have to keep that in the differential diagnosis. But your examination will help in corroborating your suspicion of a muscle disease. Let's say if you have a patient, the patient that you described, with six months' history of progressive weakness, dysphagia, and that patient has normal reflexes, and the patient has no clinical evidence for muscle fatigability and no sensory loss, then the probability that that patient has a myopathy increases. Dr Albin: Ah, that's really helpful. I'm hearing a lot of it is actually the lack of other findings. In some ways it's asking, you know, have you experienced numbness and tingling? And if not, that's sort of eliminating that this might not be a neuropathy problem. And then again, that fatigability- obviously fatigability is not specific to a neuromuscular junction, but knowing that is a hallmark of myasthenia, the most common of neuromuscular disorders. Getting that off the table helps you say, okay, well, it's not a neuromuscular junction problem, perhaps. Now we have to think more about, is this a muscle problem itself? Are there any patterns that the patients describe? I have difficulty getting up from a chair, or I have difficulty brushing my hair. When I think of myopathies, I historically have thought of, sort of, more proximal weakness. Is that always true, or not so much? Dr Milone: Yeah. So, there are muscle diseases that involve predominantly proximal weakness. For example, the patient you mentioned earlier could have, for example, an autoimmune muscle disease, a necrotizing autoimmune myopathy; could have, perhaps, dermatomyositis if there are skin changes. But a patient with muscle disease can also present with a different pattern of weakness. So, myopathies can lead to this weakness, and foot drop myopathies can cause- can manifest with the weakness of the calf muscles. So, you may have a patient presenting to the clinic who has no the inability to stand on tiptoes, or you may have a patient who has just facial weakness, who has noted the difficulty sealing their lips on the glasses when they drink and experiencing some drooling in that setting, plus some hand weakness. So, the muscle involved in muscle diseases can vary depending on the underlying cause of the muscle disease. Dr Albin: That's really helpful. So, it really is really keeping an open mind and looking for some supporting features, whether it's bulbar involvement, extraocular eye muscle involvement; looking, you know, is it proximal, is it distal? And then remembering that any of those patterns can also be a muscle problem, even if sometimes we think of distal being more neuropathy and proximal myopathy. Really, there's a host of ranges for this. I really took that away from your article. This is, unfortunately, not just a neat way to box these. We really have to have that broad differential. Let me ask another question about your history. How often do you find that patients complain of, sort of, muscular cramping or muscle pain? And does that help you in terms of deciding what type of myopathy they may have? Dr Milone: Many patients with muscle disease have muscle pain. The muscle pain could signal a presence of inflammation in skeletal muscle, could be the result of overuse from a muscle that is not functioning normally. People who have myotonia experience muscle stiffness and muscle pain. Patients who have a metabolic myopathy usually have exercise-induced muscle pain. But, as we know, muscle pain is also very nonspecific, so we have to try to find out from the patient in what setting the pain specifically occurs. Dr Albin: That's really helpful. So, it's asking a little bit more details about the type of cramping that they have, the type of pain they may be experiencing, to help you refine that differential. Similarly, one of the things that I historically have always associated with myopathies is an elevation in the CK, or the creatinine kinase. How sensitive and specific is that, and how do you as the expert sort of take into account, you know, what their CK may be? Dr Milone: So, this is a very good point. And the elevation of creatine kinase can provide a clue that the patient has a muscle disease, but it is nonspecific for muscle disease because we know that elevation of creatine kinase can occur in the setting of a neurogenic process. For example, we can see elevation of the creatine kinase in patients who have ALS or in patients who have spinal muscular atrophy. And in these patients---for example, those with spinal muscular atrophy---the CK elevation can be also of significantly elevated up to a couple of thousand. Conversely, we can have muscle diseases where the CK elevation does not occur. Examples of these are some genetic muscle disease, but also some acquired muscle diseases. If we think of, for example, cases where inflammation in the muscle occurs in between muscle fibers, more in the interstitium of the muscle, that disease may not lead to significant elevation of the CK. Dr Albin: That's super helpful. So, I'm hearing you say CK may be helpful, but it's neither completely sensitive nor completely specific when we're thinking about myopathic disorders. Dr Milone: You are correct. Dr Albin: Great. So, coming back to our patients, you know, she says that she has this dysphasia. How do bulbar involvement or extraocular eye movement involvement, how do those help narrow your differential? And what sort of disorders are you thinking of for patients who may have that bulbar or extraocular muscle involvement? Dr Milone: Regarding dysphagia, that can occur in the setting of acquired myopathies relatively frequent; for example, in inclusion body myositis or in other forms of inflammatory myopathy. Your patient, I believe, was in their forties, so it's a little bit too young for inclusion body myositis. Involvement of the extraocular muscles is usually much more common in genetic muscle diseases and much less frequent in hereditary muscle disease. So, if there is involvement of the extraocular muscles, and if there is a dysphagia, and if there is a proximal weakness, you may think about oculopharyngeal muscular dystrophy, for example. But obviously, in a patient who has only six months of history, we have to pay attention of the degree of weakness the patient has developed since the symptom onset. Because if the degree of weakness is mild, yes, it could still be a genetic or could be an acquired disease. But if we have a patient who, in six months, from being normal became unable to climb stairs, then we worry much more about an acquired muscle disease. Dr Albin: That's really helpful. So, the time force of this is really important. And when you're trying to think about, do I put this in sort of a hereditary form of muscle disease, thinking more of an indolent core, something that's going to be slowly progressive versus one of those inflammatory or necrotizing pathologies, that's going to be a much more quick onset, rapidly progressive, Do I have that right? Dr Milone: In general, the statement is correct. They tend, acquired muscle disease, to have a faster course compared to a muscular dystrophy. But there are exceptions. There have been patients with immune mediated necrotizing myopathy who have been misdiagnosed as having limb-girdle muscular dystrophy just because the disease has been very slowly progressive, and vice versa. There may be some genetic muscle diseases that can present in a relatively fast way. And one of these is a lipid storage myopathy, where some patients may develop subacutely weakness, dysphagia, and even respiratory difficulties. Dr Albin: Again, I'm hearing you say that we really have to have an open mind that myopathies can present in a whole bunch of different ways with a bunch of different phenotypes. And so, keeping that in mind, once you suspect someone has a myopathy, looking at the testing from the EMG perspective and then maybe laboratory testing, how do you use that information to guide your work up? Dr Milone: The EMG has a crucial role in the diagnosis of muscle diseases. Because, as we said earlier, weakness could be the result of muscle disease or other form of neuromuscular disease. If the EMG study will show evidence of muscle disease supporting your diagnostic hypothesis, now you have to decide, is this an acquired muscle disease or is this a genetic muscle disease? If you think that, based on clinical history of, perhaps, subacute pores, it is more likely that the patient has an acquired muscle disease, then I would request a muscle biopsy. The muscle biopsy will look for structural abnormalities that could help in narrowing down the type of muscle disease that the patient has. Dr Albin: That's really helpful. When we're sending people to get muscle biopsies, are there any tips that you would give the listeners in terms of what site to biopsy or what site, maybe, not to biopsy? Dr Milone: This is a very important point. A muscle biopsy has the highest diagnostic yield if it's done in a muscle that is weak. And because muscle diseases can result in proximal or distal weakness, if your patient has distal weakness, you should really biopsy a distal muscle. However, we do not wish to biopsy a muscle that is too weak, because otherwise the biopsy sample will result just in fibrous and fatty connected tissue. So, we want to biopsy a muscle that has mild to moderate weakness. Dr Albin: Great. So, a little Goldilocks phenomenon: has to be some weak, but not too weak. You got to get just the right feature there. I love that. That's a really good pearl for our listeners to take. What about on the flip side? Let's say you don't think it's an acquired a muscular disease. How are you handling testing in that situation? Dr Milone: If you think the patient has a genetic muscle disease, you pay a lot of attention to the distribution of the weakness. Ask yourself, what is the best pattern that represent the patient's weakness? So, if I have a patient who has facial weakness, dysphagia, muscle cramping, and then on examination represent myotonia, then at that point we can go straight to a genetic test for myotonic dystrophy type one. Dr Albin: That's super helpful. Dr Milone: So, you request directly that generic test and wait for the result. If positive, you will have proof that your diagnostic hypothesis was correct. Dr Albin: You're using the genetic testing to confirm your hypothesis, not just sending a whole panel of them. You're really informing that testing based on the patient's pattern of weakness and the exam findings, and sometimes even the EMG findings as well. Is that correct? Dr Milone: You are correct, and ideally, yes. And this is true for certain muscle diseases. In addition to myotonic dystrophy type one, for example, if you have a patient who has fascial scapulohumeral muscular weakness, you can directly request a test for FSHD. So, the characterization of the clinical phenotype is crucial before selecting the genetic test for diagnosis. Dr Albin: Wonderful. Dr Milone: However, this is not always possible, because you may have a patient who has just a limb-girdle weakness, and the limb-girdle weakness can be limb-girdle muscular dystrophy. But we know that there are many, many types of limb-girdle muscular dystrophies. Therefore, the phenotype is not sufficient to request specific genetic tests for one specific form of a limb-girdle muscular dystrophy. And in those cases, more complex next-generation sequencing panels have a higher chance of providing the answer. Dr Albin: Got it, that makes sense. So, sometimes we're using a specific genetic test; sometimes, it is unfortunate that we just cannot narrow down to one disease that we might be looking for, and we may need a panel in that situation. Dr Milone: You are correct. Dr Albin: Fantastic. Well, as we wrap up, is there anything on the horizon for muscular disorders that you're really excited about? Dr Milone: Yes, there are a lot of exciting studies ongoing for gene therapy, gene editing. So, these studies are very promising for the treatment of genetic muscle disease, and I'm sure there will be therapists that will improve the patient's quality of life and the disease outcome. Dr Albin: It's really exciting. Well, thank you again. Today I've been interviewing Dr Margarita Malone on her article on a pattern recognition approach to myopathy, which appears in the October 2025 Continuum issue on muscle and neuromuscular junction disorders. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining us today. And thank you, Dr Milone. Dr Milone: Thank you, Casey. Very nice chatting with you about this. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Clinical trials are essential for improving the lives of those diagnosed with Alzheimer's disease and related dementias. With so many trials out there, it can be difficult for someone who's interested in participating in research to know where to start. Dr. Jonathan Graff-Radford joins the podcast to discuss the ins and outs of clinical trials and the state of Alzheimer's treatments today, as well as share some highlights from his presentation at the National Alzheimer's Coordinating Center's (NACC) 2025 Spring ADRC Meeting. Guest: Jonathan Graff-Radford, MD, behavioral neurologist, associate professor, vice chair, Mayo Clinic Department of Neurology, co-investigator, Mayo Clinic Alzheimer's Disease Research Center Show Notes Read more about Dr. Jonathan Graff-Radford at his profile on Mayo Clinic's website. Listen to part one and part two of our series on preclinical Alzheimer's disease and the AHEAD study with Dr. Reisa Sperling, mentioned at 19:53, on our website. Learn more about the AHEAD study on their website. Learn more about clinical trials in Wisconsin at the UW Clinical Trials Institute's website. Interested in participating in clinical trials? Visit clinicaltrials.gov or Alzheimer's Association's TrialMatch to learn how to get involved. Learn more and register for the 2025 Fall Community Conversation: Addressing Hearing Loss for Better Brain Health on our website. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter. Enjoy Dementia Matters? Consider making a gift to the Dementia Matters fund through the UW Initiative to End Alzheimer's. All donations go toward outreach and production.

Patients Struggling With SVT/AVNRT and Catheter Ablation   Guest: Christopher DeSimone, M.D., Ph.D. Host: Anthony H. Kashou, M.D.   In this episode, Dr. Anthony Kashou and Dr. Christopher DeSimone dive into the challenges patients face with supraventricular tachycardia (SVT) and atrioventricular nodal reentrant tachycardia (AVNRT). They explore treatment options ranging from medications to catheter ablation, highlighting how these approaches aim to improve quality of life. Listeners will learn what to expect during an ablation procedure, including safety, anesthesia, and risks. Most importantly, they discuss how patients can feel empowered to make informed decisions about their care and reclaim confidence in their health.    Topics Discussed: Options and goals of current treatment options for AVNRT/SVT Catheter ablation as a means to treat and cure AVNRT/SVT What to expect and what will occur during AVNRT ablation Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

What if everything you thought you knew about cancer treatment was only half the story? In this episode of The Wellness Fix, part of The Brian Nichols Show, we uncover a jaw-dropping first-hand account that challenges the very core of “accepted” medical practice. Imagine being told at 24 years old to get your affairs in order — and then walking away, not only alive but thriving fifty years later. That's the reality of today's guest, Rick Hill. Studio Sponsor: Cardio Miracle - "Unlock the secret to a healthier heart, increased energy levels, and transform your cardiovascular fitness like never before.": CardioMiracle.com/TBNS Rick takes us back to 1974 when the Mayo Clinic delivered a terminal cancer diagnosis and offered only chemotherapy and radiation as options. Facing death, Rick received an unexpected letter that urged him to look beyond the standard treatments. What followed was a radical journey that led him across the border into Mexico — and into a new world of nutrition, natural therapies, and faith-driven resilience. This episode dives deep into Rick's recovery and the controversial role of natural compounds like B17, enzymes, and oxygen therapies. His story highlights the power of alternative approaches, not as quick fixes, but as long-term strategies rooted in God-given natural resources. Along the way, Rick exposes how big medicine often suppresses inexpensive, effective solutions to protect its bottom line. But this isn't just a story of survival. It's about trust, skepticism, and the importance of asking questions when the “experts” say there are no answers left. Brian presses Rick with the kind of skeptical questions you're probably thinking yourself: Why isn't this replicated everywhere? What about the risks? Why the pushback from doctors and regulators? The result is an honest conversation that doesn't shy away from the tension between hope and evidence. By the end, you'll be left with more than just inspiration. You'll gain practical resources, like access to Rick's book and the free download of World Without Cancer. Most importantly, you'll walk away with the reminder that hope is real, choices exist, and sometimes the greatest breakthroughs come when you're willing to think for yourself. Don't miss this powerful episode — your perspective on health may never be the same again. ❤️ Order Cardio Miracle (CardioMiracle.com/TBNS) for 15% off and take a step towards better heart health and overall well-being!

In this episode, I'm talking with Medha Kaul a research data analyst in the Division of Epidemiology at Mayo Clinic about her job and the research she is doing!

Big changes are here for student loans—and if you're a doctor, student, or high-debt professional, this episode could save you thousands. Dr. Disha Spath sits down with Aaron Smith, co-founder of Savi and longtime student loan policy advocate, to break down the One Big Beautiful Bill Act and what it really means for your financial future. Aaron has worked with the Department of Education, Congress, and the White House—and he's carried student debt himself. Together, he and Dr. Disha unravel the brand-new Repayment Assistance Plan (RAP), the elimination of Grad PLUS loans, and how these reforms reshape repayment strategies, PSLF, and refinancing decisions. Key Topics Covered: 1. The Big Beautiful Bill, Simplified What's changing in federal student loan repayment. Which repayment plans are gone, and the details behind RAP. 2. RAP vs. Current Plans Why RAP bases payments on gross income. Why locking into an income-driven repayment plan before 2026 could be a smart move. 3. PSLF Stays Strong  The good news: PSLF wasn't touched by the new law. How to avoid errors with employer certification and payment tracking. 4. Goodbye Grad PLUS Loans How cutting Grad PLUS reshapes graduate and medical school financing. What rising reliance on private loans means for lower-income students. 5. Smart Moves for Current Borrowers How to maximize forgiveness and avoid costly mistakes. Critical timelines for choosing your repayment plan. 6. Should You Refinance? When private refinancing could save you money—and when it locks you out of forgiveness forever. What falling interest rates might mean for borrowers in 2025–2026. 7. Employer Support & Advocacy How hospitals, universities, and employers are stepping up with student loan benefits. Why employer advocacy is helping expand PSLF eligibility. Listener Takeaways: Act before July 2026: Enroll in an income-driven plan now to keep your options open. PSLF is safe—but annual employer certification is key to avoiding lost credits. Future grad students beware: With Grad PLUS gone, private loans will change the game. Refinancing is final: weigh lower interest rates against losing federal protections. Stay plugged in—loan policy is shifting fast, and being proactive could save you years of payments. Resources Mentioned: Black Swan Real Estate Savi Student Loan Platform Secure Freedom Fund U.S. Department of Education PSLF Help Tool Connect with Us: Host: Dr. Disha Spath, The Frugal Physician Guest: Aaron Smith, Co-Founder of Savi   This episode is brought to you by Black Swan Real Estate, led by physician-investor Dr. Elaine Stageberg.  Dr. Stageberg, a Mayo Clinic–trained physician, together with her husband Nick, has spent years building Black Swan Real Estate into a diversified, large-scale portfolio now approaching half a billion dollars across 2,000 doors.  Now, through their Secure Freedom Fund, a 10% fixed rate of return offering, you can invest alongside them. The Secure Freedom Fund offers institutional-quality real estate opportunities—designed to deliver strong cash flow, long-term growth, and remarkable tax advantages.  This fund is uniquely structured so that each investor can tailor it to their own individual goals: a minimum investment of just $25,000, the ability to choose monthly cashflow distributions or to elect the compounding option for higher overall growth, the option to exit the fund on your timing, the flexibility to invest in your personal name, a trust, an LLC, or a retirement account, and so much more.  If you're an accredited investor who's ready to diversify beyond Wall Street and invest with experienced, trust worthy operators who've been exactly where you are, visit SecureFreedomFund.com today to learn more. From there, you can review the slides, watch the webinar, and even a book a call directly 1:1 with Dr. Elaine Stageberg.  That's SecureFreedomFund.com.

In this episode of Tech It To The Limit, hosts Sarah Harper and Elliot Wilson revisit generational myths in digital health and reveal why age isn't the real barrier to adoption. Through their new game, Fact Check Fever, and a deep dive into the Capability-Motivation-Context (CMC) framework, they show how design, usability, and trust matter far more than birth year. From busting stereotypes to exploring how health systems can design with users, not for them, it's a witty, insightful look at the future of inclusive, human-centered innovation.Key TakeawaysGenerational myths don't hold up: Boomers use portals, Gen Z cares about privacy, and every group struggles with clunky design, not just “digital natives.”Design trumps demographics: Adoption isn't about age, it's about usability, accessibility, and human-centered design.Follow the CMC framework: Capability, motivation, and context, not birth year, to predict whether people engage with health tech.Health equity requires intention: Neutral AI does not exist; equity has to be actively built into technology.The biggest unifier isn't age: A diagnosis, condition, or shared health journey brings people together across generations more than labels like Boomer or Gen Z.In this episode:[00:00:13] Welcome & episode introduction[00:00:55] Recap of Mayo Clinic live show[00:02:36] Looking ahead to HLTH: speakers, tracks, and the health tech “fashion week” vibe[00:05:08] Conference tracks & awards00:07:13] Launching Fact Check Fever: busting myths on portals, EHR burnout, Gen Z TikTok habits, and more[00:07:37] Fact Check Fever: generational myths & data[00:19:24] Break for fake sponsor: Patient Portal Plus Plus[00:20:44] Sincere segment: CMC framework for health tech adoption[00:22:24] Deep dive: CMC framework explained[00:31:17] Designing with, not for, users[00:35:31] Break for fake sponsor: Bias Focals[00:37:14] Spicy Nugs: co-host lightning round[00:46:41] Closing thoughts, HLTH call-to-action, and Elliot's health tech haikuResourcesTech It To The Limit PodcastWebsite Apple PodcastSarah HarperLinkedIn -https://www.linkedin.com/in/sarahbethharperElliott WilsonLinkedIn - https://www.linkedin.com/in/matthewelliottwilson

Published October 2, 2025 In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, discuss the latest developments in self-collection testing for women's health and beyond. Together, they explore:New podcast format launching (00:01): Dr. Pritt previews exciting changes coming to “Answers From the Lab.” Emerging self-collection tests (01:21): Explore the growing range of self-collection tests now available for use in both clinical settings and at home.Validation of self-collection tests (03:19): Learn how laboratorians validated recent self- and home-collection tests to ensure quality and accuracy. Benefits for patients and public health (06:56): Understand the benefits self-collection tests offer to patients and how the tests impact public health.Limitations and implementation considerations (08:23): Review key factors to consider when incorporating self-collection testing into clinical care.Future innovation (11:34): Insights into where self-collection testing may evolve in the years ahead.

This week marks the 10th anniversary of the Kahn Center for Cardiac Longevity—thank you for being part of the journey! Dr. Kahn reviews important new Mayo Clinic data comparing causes of heart attacks in men vs. women under 65. The findings show that non-traditional causes are significantly more common in women. Because the study ended in 2018, neither COVID nor vaccine-related data were included. In addition, Dr. Kahn covers a range of timely health topics: Sucralose (Splenda) and cancer therapy Magnesium for hypertension Eating early vs. late in the day Hydration and survival The ongoing debate over whether meat promotes or protects against cancer deaths (spoiler: it does not) Thanks to Igennus.com—use discount code DrKahn for savings. And don't miss the group PROLON fast beginning October 5, 2025. Order your kit now at prolonlife.com/drkahn.

Heart attacks aren't just an older generation's issue anymore. A new Mayo Clinic study shows that 1 in 10 heart attacks in women under 40 are linked to stress, anemia, overexercising, and postpartum recovery — not clogged arteries. In this episode, Coach Cynthia explains these hidden risks and how moms can protect their heart health, reclaim energy, and create a calmer, healthier home.  

When radiology meets surgery, endometriosis care becomes more precise, personalized, and proactive. In this BackTable OBGYN Brief, host Dr. Mark Hoffman is joined by Dr. Wendaline VanBuren, an associate professor of radiology at Mayo Clinic, and Dr. Tatnai Burnett, a minimally invasive GYN surgeon at Mayo Clinic, to discuss the complexities of diagnosing and managing endometriosis. The discussion covers the roles of advanced imaging techniques like MRI and ultrasound, the importance of pre-surgical planning, and the need for multidisciplinary collaboration. They share their approach to managing symptomatic and asymptomatic patients, the use of hormonal treatments, and the significance of monitoring potential malignant transformations in endometrioma cases. The episode underscores the critical role of imaging in planning effective surgical interventions for patients while highlighting the progression of endometriosis management protocols. TIMESTAMPS 00:00 - Introduction  01:07 - Discussing Endometriosis Management 02:18 - Imaging Techniques and Their Importance 04:24 - Interdisciplinary Collaboration 05:40 - Advanced Imaging Protocols 08:12 - Monitoring and Follow-Up Strategies 08:50 - Concerns About Malignancy 11:04 - Future Directions CHECK OUT THE FULL EPISODE OBGYN Ep. 69 https://www.backtable.com/shows/obgyn/podcasts/69/imaging-protocols-to-guide-endometriosis-treatment

Effects of Social Isolation and Loneliness on the Heart   Guest: Amir Lerman, M.D. Host: Stephen L. Kopecky, M.D.   Social isolation and loneliness are common, mainly in the elderly, and are regarded as major cardiovascular risk factors. The factors are associated with an increase in cardiovascular events and mortality. Additionally, social isolation and loneliness are associated with increased systemic inflammation and progression of atherosclerosis   Topics Discussed: How do you identify social isolation? Mechanism of social isolation and loneliness on CV health Prevalences and risk of social isolation and loneliness Findings of a recent study from Mayo Clinic Case story: the Roseto effect Potential therapy    Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Welcome to Ozempic Weightloss Unlocked, where we dive into the latest breakthroughs and controversies surrounding Ozempic, its medical use, and its impact on everyday wellness.The big headline this month is the arrival of a new pill form of semaglutide, the main ingredient in Ozempic. According to The New England Journal of Medicine, people who took this daily pill lost almost 14 percent of their body weight over 64 weeks, compared to just 2 percent for those on a placebo. Fifty percent of the patients shed at least 15 percent of their weight, with nearly a third losing 20 percent or more. Novo Nordisk, the company that makes Ozempic, announced even stronger results for those who stuck to their treatment plan, with close to 17 percent average weight loss. This pill, pending approval, could be a game changer for people who prefer not to take injections.On the injectable front, clinical trials featured in The Lancet indicate that a higher 7.2 milligram weekly dose of semaglutide in adults without diabetes led to almost 19 percent average weight loss, higher than what's seen with lower doses. These numbers highlight ongoing efforts to increase the effectiveness of Ozempic for those struggling with obesity.Yet, it's crucial to balance these promising results with real-world insights. The Mayo Clinic and NYU Langone Health recently compared Ozempic's results to traditional weight loss surgery, like gastric bypass and sleeve gastrectomy. Their research revealed that surgery is five times more effective than GLP-1 drugs such as Ozempic, with surgical patients losing an average of 58 pounds after two years versus just 12 pounds for those on the drug for six months. Experts also noted that only 30 percent of patients stick with GLP-1 drugs for longer than a year, and real-world weight loss may be lower than trial results suggest. Surgery, however, isn't without its risks, including potential infections, blood clots, and hernias, and requires strict diet and lifestyle changes afterward.Turning to genetics, Cleveland Clinic research shows that the effectiveness of Ozempic may depend on your DNA. A specific variant in the Neurobeachin gene seems to make some people much more responsive to these medications, leading to 82 percent higher odds of substantial weight loss. This new insight could help doctors tailor treatments so patients get therapies most suited to their genetic profile.Lifestyle stakes are high, and so are concerns about side effects and safety. Recent studies report that Ozempic may cause severe conditions such as gastroparesis, bowel blockages, pancreatic and kidney injuries, and vision problems. Even hair loss is emerging as a potentially significant side effect, especially for women—according to recent findings, female users experienced about twice the rate of hair loss compared to those not using Ozempic.Because of these risks, there are currently over two thousand active lawsuits against Novo Nordisk and other GLP-1 manufacturers, with ongoing multidistrict litigation. These lawsuits allege that the companies did not give enough warning about the dangers, and some patients claim life-changing or life-threatening complications.Compounded GLP-1 drugs, made in pharmacies rather than by pharmaceutical companies, became popular when Ozempic was in short supply. However, the FDA warns that compounded drugs can be risky because they're not evaluated for safety or effectiveness. While the shortage has officially ended, compounded formulations remain in circulation.If you are considering Ozempic—whether as a pill, injection, or a compounded version—talk with your healthcare provider and review your health history, genetic background, and lifestyle goals. Widespread interest has led to changing availability, promising new forms, and more transparent labeling, especially after recent updates about kidney and pancreatic risks.To sum up, Ozempic continues to make waves as both a treatment for diabetes and a potent tool for weight loss. With fresh news about new pill forms, higher effective doses, genetic influences, and ongoing legal cases, it's important to stay informed and make choices based on both science and your personal health needs.Thanks for tuning in to Ozempic Weightloss Unlocked. Don't forget to subscribe to stay up to date on the latest developments. This has been a Quiet Please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Beginning this Sunday, Oct. 5 at 5am WGCU will begin airing a weekly interview show called “What's Health Got to Do With It?” that explores the intersection of healthcare and daily life with a focus on guiding listeners on their journeys through the increasingly convoluted medical bureaucracy. We meet its host, Dr. Joe Sirven. He's a practicing neurologist, and professor of neurology and Chairman Emeritus of the Department of Neurology at the Mayo Clinic in Arizona. He's also a well-published author on epilepsy, a former editor-in-chief of epilepsy.com, and he currently serves as the editor-in-chief of Brain & Life en Español.

In 1974, doctors at the Mayo Clinic in Rochester, Minnesota, delivered grim news. They scheduled him for chemotherapy and advised him to bring his family to say their goodbyes. But Rick Hill defied the odds—and the conventional path.Rick Hill's story is more than a tale of survival—it's a legacy of hope, determination, and advocacy for transparency and choice in cancer treatment.For those seeking inspiration in the face of adversity, Rick Hill's life proves that even the darkest diagnoses can lead to a brighter future.

See omnystudio.com/listener for privacy information.

Across healthcare, new technologies often land in the hands of nurses without their input, adding complexity instead of easing it. In the age of artificial intelligence, more than ever, leaving nurses out of the design process risks creating tools that miss the mark, fail to build trust, threaten safety and security, and can add to the very burdens they're meant to relieve.  In this episode of our AI in Play series, we meet Ryannon Frederick, MS, RN, System Chief Nursing Officer at Mayo Clinic, who has restructured nursing leadership teams to ensure nurses identify the problems, co-develop the solutions, and remain partners from design through implementation and testing. Frederick shares how this “for nurses, by nurses” model is transforming innovation at Mayo, making nursing work visible, rebuilding trust in technology, and delivering tools like ambient documentation and nurse virtual assistants that give time back to patients and strengthen the workforce.  Find this episode's resources at www.seeyounowpodcast.com, and for more information on the podcast bundles, visit ANA's Innovation Website at:  https://www.nursingworld.org/practice-policy/innovation/education/.  Have questions for the SEE YOU NOW team? Feedback? Future episode ideas?   Contact us at: hello@seeyounowpodcast.com.    Resources  Enabling nurses' engagement in the design of healthcare technology – Core competencies and requirements: A qualitative study (2024) BMC Nursing. https://www.sciencedirect.com/science/article/pii/S2666142X23000541?via%3Dihub  Impact of Bottom-Up Cocreation of Nursing Technological Innovations: Explorative Interview Study Among Hospital Nurses and Managers (2025).JMIR. https://humanfactors.jmir.org/2025/1/e60543/  Global prevalence and contributing factors of nurse burnout: an umbrella review of systematic review and meta-analysis. (2025) BMC Nursing. https://bmcnurs.biomedcentral.com/articles/10.1186/s12912-025-03266-8  Documentation Burden in Nursing and Its Role in Clinician Burnout Syndrome. (2022) ACI.  https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0042-1757157  Addressing burnout in the healthcare workforce: current realities and mitigation strategies. (2024) The Lancet. https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00128-5/fulltext 

Discover expert insights on kidney stone prevention and management in this podcast episode featuring a physician, dietitian, pharmacist, and patient. Learn about key kidney stone risk factors and explore how dietary adjustments can reduce stone recurrence. Experts discuss fluid intake strategies, medication considerations, surgical indications, and even unconventional questions about roller coasters' impact on stone passage. Tune in for actionable advice, myth-busting discussions, and interprofessional perspectives.   On today's episode we heard from: Melanie Betz, MS, RD, CSR, FNKF, FAND is a nationally recognized renal dietitian and the Founder & CEO of The Kidney Dietitian. She is a Certified Specialist in Renal Nutrition and a Fellow of both the National Kidney Foundation and the Academy of Nutrition & Dietetics. Melanie has published extensively on kidney stone prevention and nutrition, and has presented at numerous state, national, and international conferences on the topic. Through her clinical work, research, and educational outreach, she is dedicated to helping patients and professionals understand the critical role of diet in kidney health. Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS is a Clinical Associate Professor at West Virginia University School of Pharmacy and a Clinical Pain & Addiction Pharmacist. With expertise in pain management, substance use disorders, and geriatric care, he brings both clinical and personal perspectives to kidney stone discussions. Mark has shared his experience through the Pain Pod podcast, PAINWeek presentations, and a published article detailing his own kidney stone journey. Mary Raines, CRA is a retired clinical research associate with more than 30 years of experience in medical research. After learning she needed a kidney transplant, she dedicated herself to advocacy and now serves as a Patient Advocate with the National Kidney Foundation and other kidney health organizations. Mary brings both professional expertise and personal experience to her work, amplifying the voices and needs of people living with kidney disease. Andrew Rule, MD, MSc is a Professor of Medicine and Consultant Nephrologist at the Mayo Clinic in Rochester, Minnesota. He divides his time between clinical care, research, and education, with a particular focus on kidney stone disease and its link to chronic kidney disease. Dr. Rule has published extensively on the epidemiology of kidney stones and provides specialized care in the Mayo Clinic's nephrology stone clinic. Bryan Tucker, DO, MS, FASN is an Assistant Professor of Medicine in Nephrology at Baylor College of Medicine, where he serves as a clinician educator teaching medical students, residents, and fellows while caring for patients in both inpatient and outpatient settings. He holds a master's degree in nutrition from Columbia University and completed his nephrology fellowship at Yale. A Fellow of the American Society of Nephrology, Dr. Tucker has authored numerous peer-reviewed publications and book chapters and is an active contributor to The Kidney Commute podcast.   Additional Resources: Kidney Stone Information Earn CME Credit Here Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.  

Earlier this week, President Trump and his Administration made claims about the correlation between autism and Tylenol or acetaminophen use during pregnancy, warning pregnant women not to use the drug. A mounting backlash has followed with medical and autism experts alike disagreeing with Trump's claims. The American College of Obstetricians and Gynecologists and the American Academy of Pediatrics continue to recommend acetaminophen in pregnancy and childhood when used at the lowest dose for the shortest duration. Mayo Clinic trained Rheumatologist Dr. Alfred Miller takes aim with the claims and believes the Trump Admin. is ignoring scientific studies regarding autism. Dr. Miller joined us to discuss.

En Guerrero Marina y FGR incineran 900 kilos de cocaína  Oaxaca ordena a burócratas usar ropa indígena cada miércoles  Daniel Hidalgo será nuevo presidente de la Academia de Cine  Más información en nuestro podcast

A-Block (2:30) SPECIAL COMMENT: After perhaps the most hapless 96 hours of his presidency, the worst 96 hours of the worst presidency of ALL TIME, the most FAIL in the shortest span… the mentally-deteriorating, untethered-from-reality Trump… must RESIGN. And take his idiot sycophants with him. The last 96 hours: His U.N. speech, sounding like an escapee from a psych ward. His Tylenol news conference, sounding like an escapee from a psych ward who’s been living on the street for a month. His suggestion NATO countries shoot down Russian jets. His sudden embrace of Zelensky, either another stall or a stupid dare to Putin. MAGA’s RAGE AT his sudden embrace of Zelensky. The cover of a London right wing daily: his picture and in 72-point type, the word “DERANGED.” The ICE shooting in Dallas; his sadistic Homeland chief pretending the victims were agents when they were detainees; his idiot simpering Vice President pretending the victims were agents when they were detainees; his corrupt venal FBI director pretending the victims were agents when they were detainees. His ICE chief not denying he took $50,000 in a paper bag. His staff THEN denying he took $50,000 in a paper bag. His cancellation of a meeting with Democrats making sure if there’s a government shutdown it’s all his fault. His crackpot pal Milei crashing the Venezuelan economy and needing us to bail him out. His paranoia over the stopped teleprompter at the U-N that was his White House staff’s fault. His paranoia over the stopped escalator at the U-N that was his own vanity videographer’s fault. His desire to arrest the U.N. escalator technician or the U-N escalator button pusher. His desire to arrest the escalator AND James Comey. The election of Raul Grijalva’s daughter to Congress. The fact that Adelita Grijalva will be the last Representative needed to force a vote on releasing the Trump Epstein Files. His self-humiliation at the Kirk Memorial. ABC reinstating Jimmy Kimmel. Meaning Disney told him to eff off. Meaning the National Football League told him to eff off. Meaning they all told his propagandists at Sinclair to eff off. Kimmel then shoving him in a locker using only a monologue. Kimmel getting a record 6 million viewers and 22 more online in the first TWENTY hours. Kimmel and his show getting new life and maybe a new contract. His self-owning confession that HE and his goons used threats to get Kimmel cancelled. The fact that Kimmel, and ABC, and Bob Iger, and Disney, and America told Trump to SHOVE HIS THREATS. And that’s just since Sunday night. You lost to an escalator. Resign. Take Vance with you. Take Noem with you. Take Ho-man with you. Take Milei with you. LEAVE the Epstein Files. B-Block (32:53) THE WORST PERSONS IN THE WORLD: Jason Whitlock says eff everybody, this is Christ-land and he won't be brainwashed any more (no brain, no pain). Derrick Van Orden says Kirk was Jesus and you don't F with the Jesus so defund The Mayo Clinic (he should go there and get CT scanned) and Kristi Noem says a tweet saying she'd have a bad day was terrifying for her. This is a piece of crap who in her spare time murders puppies. C-Block (42:00) THINGS I PROMISED NOT TO TELL: The New York Post BS firehose points at a couple of liberals at a time, then it rotates away, but eventually it makes a full circle and comes back to you. For me this has been going on since the mid-1990's and it's just started again. If you'll permit, here's a brief history.See omnystudio.com/listener for privacy information.

In this episode, Bill and Michael unpack the “Last 8%” of conversations — the toughest parts we often avoid but that carry the most impact. They explore how leaders can build cultures of high connection and high courage, share personal stories from healthcare and startup leadership, and offer strategies for handling tough truths, hiring challenges, and team performance. Bill Benjamin, a global keynote speaker who blends practicality with science in his approach to leadership. With degrees in Mathematics and Computer Science, Bill uses brain-science to help people master emotional intelligence, perform under pressure, and build what he calls a high-performance “Last 8%” culture. Audiences appreciate his high energy and engaging style, whether he is speaking to surgeons, the U.S. Marines, NASA engineers, or executives at Amazon, Intel, and Goldman Sachs. Bill does not just share theory. He is open about the struggles he faced early in his career and how applying the strategies he now teaches made him a stronger leader, husband, and father. He is funny, relatable, and committed to understanding the real challenges organizations face, weaving those directly into his sessions. That is why top organizations from the Mayo Clinic to NASA trust him when performance and leadership matter most. HBR Article:  https://hbr.org/2025/09/the-secret-to-building-a-high-performing-team Website: https://ihhp.com/  

In this episode of the Optimal Aging Podcast, Jay Croft speaks with Dr. Jonathan Graff-Radford, a Mayo Clinic neurologist and co-author of the new edition of the Mayo Clinic Guide to Alzheimer's and Other Dementias. They discuss how Alzheimer's disease begins 20 years before symptoms appear, what can be done to prevent or delay it, and what health and fitness professionals working with people over 50 need to know now.Dr. Radford shares powerful new insights on early detection tools, lifestyle factors like exercise and hearing loss, and how fitness protocols can support cognitive health. You'll also hear how dual-tasking workouts, VO2 max, and neuroplasticity play a role in long-term brain health.If you serve older adults in health, fitness, or wellness, this is a must-listen.

We start with the on-going invasion of many Wisconsin communities by energy and water sucking data centers. While profiting Silicon Valley, Wall Street, and Big Utilities these projects threaten to accelerate runaway climate change and spike already unaffordable utility prices. While state and local economic development boosters, including the Evers Administration, throw public money at data centers without considering the massive environmental costs and limited economic impact, a few brave communities are standing up in places such as Menomonie and Caledonia. We need to refocus public policy on addressing the climate crisis, not economical development boondogles that light the planet on fire. We encourage people to attend this Sunday's Climate March at the Capitol in Madison at Noon. Meanwhile Trump, Vance, and their minions rush to politicize the violent attack on ICE office in Dallas before the facts are in, blaming Democratic and left wing truth-telling about the abuses of Trump's immigration crackdown. There is a problem with political incendiary language, that it come from the President, Vice President, and MAGA, not elected progressives and mainline Democrats. We talk about the potential of a government shutdown, and the Trump Regime impact in Wisconsin this week, including Derrick Van Ordin's demand to cut off federal dollars to the City of Eau Claire, Ellsworth, and Mayo Clinic in retaliation for social media posts. Citizen Action Board member and former state Representative Sandy Pasch joins us to warn our listeners about a terrible new bill in Madison that restricts free speech in the name of fighting antisemitism by making legitimate and First Amendement protected cricism of Israel into hate speech. The bill is yet another authoritarian attempt to empower governmet crackdowns against civil society groups and free speech. Sandy calls for our listeners to reach out to their state representative and senators to oppose AB 446, and support alternative legislation that meaningfully addresses antisemitism. Finally, we welcome Chris Gooding, Theology professor and union leader at Marquette University, to update our listeners on the Jesuit university's union busting in the name of God. We discussed how this anti-union strategy spread this month to Loyola Marymount University in Los Angeles, where the university walked away from negotiations with their workers, prompting outrage on campus and a strike vote.

FRIENDS AND ENEMIESThis week we welcome two esteemed medical professionals to discuss the state of Canadian healthcare, surgery wait times, the rise in demand for private care options in Canada, and more.A little about our guests:Dr. Brian Day is a prominent Canadian orthopedic surgeon, health researcher, and advocate for reforming the Canadian healthcare system, known for his controversial stance favoring private healthcare options and his legal challenge to B.C.'s Medicare Protection Act, which he ultimately lost. He is the founder of the Cambie Surgery Centre in Vancouver and a former president of the Canadian Medical Association. His advocacy is detailed in his book, "My Fight for Canadian Healthcare," and he remains a significant figure in discussions about healthcare policy in Canada.Dr. Mohammad Zarrabian is the current Head of Spine Surgery at Hamilton Health Sciences. He is a double fellowship-trained spine surgeon, having completed neurosurgical and orthopedic spine surgery fellowships at the Mayo Clinic and Toronto Western Hospital, University of Toronto. Buy Dr. Day's Book Here: https://a.co/d/4bKrBhE____Join us for some QUALITY Bitcoin and economics talk, with a Canadian focus, every Monday at 7 PM EST. From a couple of Canucks who like to talk about how Bitcoin will impact Canada. As always, none of the info is financial advice. Website: ⁠www.CanadianBitcoiners.com⁠Discord: https://discord.com/invite/YgPJVbGCZX A part of the CBP Media Network: ⁠www.twitter.com/CBPMediaNetworkThis show is sponsored by: easyDNS - https://easydns.com EasyDNS is the best spot for Anycast DNS, domain name registrations, web and email services. They are fast, reliable and privacy focused. With DomainSure and EasyMail, you'll sleep soundly knowing your domain, email and information are private and protected. You can even pay for your services with Bitcoin! Apply coupon code 'CBPMEDIA' for 50% off initial purchase Bull Bitcoin - ⁠⁠https://mission.bullbitcoin.com/cbp⁠⁠ The CBP recommends Bull Bitcoin for all your BTC needs. There's never been a quicker, simpler, way to acquire Bitcoin. Use the link above for 25% off fees FOR LIFE, and start stacking today.256Heat -⁠ https://256heat.com/ ⁠ GET PAID TO HEAT YOUR HOUSE with 256 Heat. Whether you're heating your home, garage, office or rental, use a 256Heat unit and get paid MORE BITCOIN than it costs to run the unit. Book a call with a hashrate heating consultant today.The Canadian Bitcoin Conference - https://canadianbitcoinconf.com/The PREMIER Bitcoin Conference, held annually in the great white North, where Bitcoiners come together to share stories, build momentum and have a great time while doing so. Whether your a pleb, business, newcomer or OG, the Canadian Bitcoin Conference wants to see you in Montreal, October 16-18 2025. Don't miss this one!

Send us a textThe world of invisible illness is a lonely place where "you look fine" becomes a painful refrain from well-meaning friends and family who can't see the war raging inside your body. For six years, I've navigated life with rheumatoid arthritis—an autoimmune disease where my body attacks my joints, causing inflammation, pain, and progressive damage from my fingers to my hips.This deeply personal episode peels back the curtain on what it's truly like living with chronic pain that others can't see. I share my diagnosis story, the countless medications and supplements that fill my daily routine, and how I've had to completely reimagine my identity. From the steroid shots that provide temporary relief to the heated blankets that have become my constant companions, I walk you through the practical realities of managing an autoimmune disease.But beyond the physical challenges lies a profound psychological journey. I've discovered what I call the "migraine hack"—how people readily show empathy for conditions they understand while dismissing autoimmune flares with a casual "can't you just suck it up?" I share the valuable Column A, B, C exercise from the Mayo Clinic that's helping me accept my new reality: Column A represents who I was before, Column C reflects my worst days, and Column B is the new identity I'm creating between those extremes.Whether you're battling an invisible illness yourself or love someone who is, this conversation offers both practical insights and emotional validation. For those suffering, you're not alone in this struggle. For those supporting someone with chronic illness, understanding is the greatest gift you can offer. Because when someone says they're in pain, believing them costs nothing—but dismissing their experience costs them everything. Thanks again for listening. Don't forget to subscribe, share, and leave a FIVE-STAR review.Head to Dwanderful right now to claim your free real estate investing kit. And follow:http://www.Dwanderful.comhttp://www.facebook.com/Dwanderfulhttp://www.Instagram.com/Dwanderful http://www.youtube.com/DwanderfulRealEstateInvestingChannelMake it a Dwanderful Day!

In this episode of the Investing in Integrity podcast, Ross Overline, CEO and co-founder of Scholars of Finance, welcomes Bill George, Legendary Business leader and former CEO of Medtronic, Harvard Business School professor, and board member at Goldman Sachs, for a candid conversation on authentic leadership in finance. Drawing on decades of executive and boardroom experience, Bill highlights why integrity, emotional intelligence, and purpose-driven decision-making are vital in today's financial landscape. Together, they discuss strategies for combating greed, building sustainable long-term value, and staying true to one's moral compass even in high-stakes environments. The discussion also explores navigating ethical challenges in the age of AI and ensuring finance remains a force for good. Whether you're an aspiring finance professional or a seasoned investor, this episode offers valuable insights on leading with character and transforming business through values-based leadership.Meet Bill George:Bill George is an Executive Education Fellow at Harvard Business School and former chairman and CEO of Medtronic, where he led from 1991 to 2001. Earlier in his career, he held senior roles at Honeywell, Litton Industries, and the U.S. Department of Defense. A prolific author, Bill has written several influential books on authentic leadership, including True North. He has served on the boards of Goldman Sachs, ExxonMobil, Novartis, Target, and the Mayo Clinic. Recognised with honors such as the Bower Award for Business Leadership, Bill is widely respected for advancing values-driven leadership in business and society.

Host: Darryl S. Chutka, M.D. Guest: Matthew (Mark) Melin, M.D. Vascular wounds can be quite challenging. If untreated, they can lead to infection, even sepsis, hospitalization and occasionally, amputation. Effective treatment requires an accurate diagnosis and recognition of the specific type of vascular wound you're dealing with. Even when the type of wound is correctly identified and is being treated appropriately, healing can be slow. What diagnostic tools are available to help us? How does a venous insufficiency ulcer differ from an arterial ulcer? What's the best treatment for these wounds and when should we refer our patient to a vascular specialist? The topic for this podcast is “Vascular Wound Treatments” and these are some of the questions I'll be asking my guest, Matthew (Mark) Melin, M.D., a vascular specialist from the Department of Cardiovascular Medicine at the Mayo Clinic. Mayo Clinic Talks: Vascular "What's Circulating" | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Ischemia with No Obstructive Arteries (INOCA) in 2024    Guest: Claire Raphael, M.B.B.S., Ph.D. Host: Sharonne Hayes, M.D.   INOCA is a common condition. It is an acronym that stands for ischemia with non-obstructive coronary artery disease. We discuss when to consider a diagnosis of INOCA, how to diagnose it and how to treat patients.   Topics Discussed: What is INOCA? Who is at risk for INOCA? How do we manage INOCA?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Welcome to the Oncology Brothers podcast! In this episode, we dive deep into the world of neuroendocrine tumors (NETs) with renowned expert Dr. Thor Halfdanarson from the Mayo Clinic. Join us as we explore: •⁠  ⁠The critical factors in diagnosing NETs, including origin, grade, histological features, and Ki-67. •⁠  ⁠The importance of differentiating between functional and non-functional tumors and how this impacts treatment decisions. •⁠  ⁠Dr. Halfdanarson's treatment paradigm, including the use of somatostatin analogs, radioligand therapy, and other targeted treatments. •⁠  ⁠Monitoring strategies for patients, including the role of imaging and tumor markers like 5-HIAA and chromogranin. •⁠  ⁠Insights into the evolving role of immunotherapy and next-generation sequencing in managing high-grade neuroendocrine carcinomas. Whether you're a healthcare professional or simply interested in the latest advancements in oncology, this episode is packed with valuable information and practical insights. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more discussions on cutting-edge cancer treatments and expert opinions in the field of oncology!

Should MRI-guided interventions be on your radar? Find out why the future of interventional radiology might lie in MRI guidance with experts Dr. Clifford Weiss from Johns Hopkins University and Dr. David Woodrum from the Mayo Clinic.---This podcast is supported by:Medtronic Emprinthttps://www.medtronic.com/emprint---SYNPOSISThe physicians join host Dr. Chris Beck to explore the benefits of MRI guided procedures, including superior imaging capabilities and reduced radiation exposure. Dr. Weiss and Dr. Woodrum detail the challenges and barriers to adoption, like the intricate set up needed to protect equipment from a strong magnetic field. They highlight the significant technological advancements and collaborations between MRI and device companies that are set to make MRI guided interventions more accessible and practical for everyday use. They also discuss the reimbursement paradigm for MRI guided biopsies and how similar the algorithm is to CT guided procedures.The episode closes with unique insights for young physicians on training opportunities and the promising future of MRI guided interventions for trainees looking to bring a different approach to their future practices.---TIMESTAMPS00:00 - Introduction05:13 - The Advantages of MRI in Interventional Radiology13:44 - Technical Insights and Challenges of MRI Guided Procedures18:46 - Future Prospects and Industry Developments in MRI Guided Interventions31:01- Development of Hybrid MRI Rooms48:19 - Economic Considerations and Reimbursement52:33 - Community Support for MRI Interventions56:41 - Conclusion and Final Thoughts---RESOURCESInternational Society for Magnetic Resonance in Imaging:https://www.ismrm.org/

Host: Darryl S. Chutka, M.D. Guest: Neha P. Raukar, M.D., M.S. Women in medicine have made significant strides over the past few decades, yet some still face a variety of challenges and barriers. They commonly encounter inequalities that can affect their professional growth and overall well-being. Common issues include pay disparity, underrepresentation in leadership positions and gender discrimination, just to name a few. Some medical specialties tend to be male-dominated and can be less welcoming to women. As a result, women physicians have higher rates of professional burnout and often experience a less satisfying career. My guest for this podcast is Neha P. Raukar, M.D., M.S., an emergency medicine physician at the Mayo Clinic. The topic we'll be discussing is “Claiming Your Voice and Why Women in Medicine Need a Clear Professional Narrative”. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

What does a longevity doctor actually do and how is this different from what you'd get from a traditional doctor, holistic practitioner, or even functional medicine expert? In this episode, I sit down with Dr. Darshan Shah, a longevity doctor based in Los Angeles, to uncover what “next-level health” looks like when science meets cutting-edge treatments you won't find anywhere else. We dive straight into some of the most advanced therapies and what they really mean for midlife women: Therapeutic Plasma Exchange and why this is becoming a hot topic in the world of anti-aging and disease prevention NAD treatments: are they truly beneficial, or is it time to reconsider how we approach NAD? Breast health and screening: what every woman should know and why early detection strategies are evolving Darshan Shah, MD, is a health and wellness specialist, board-certified surgeon, published author, entrepreneur, and founder of Next Health, the first, largest and fastest-growing health optimization and longevity clinic.  He began his career at an accelerated MD program and earned his medical degree at the age of 21, becoming one of the youngest doctors in the United States. He continued his training at the Mayo Clinic, and earned his MBA from Harvard Business School in 2015.As a longevity medicine specialist, he has advised thousands of patients on how to optimize their well-being and extend their healthspan and lifespan.    Extend with Dr. Darshan Shah Podcast: https://podcasts.apple.com/us/podcast/welcome-to-extend-with-darshan-shah-md/id1773578243?i=1000673875409  Episode with Dr. Sara Szal (Gottfried) https://podcasts.apple.com/us/podcast/89-sara-szal-md-why-80-of-women-experience-brain-fog/id1773578243?i=1000723568927 https://www.drshah.com/biomarkers Contact Dr. Darshan Shah Website: https://www.next-health.com/ Instagram: https://www.instagram.com/darshanshahmd  Email: contact@drshah.com   Give thanks to our sponsors: Try Vitali skincare. 20% off with code ZORA here https://vitaliskincare.com Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.  Get Mitopure Urolithin A by Timeline. 20% discount with code ZORA at https://timeline.com/zora Try Suji to improve muscle 10% off with code ZORA at TrySuji.com  Try OneSkin skincare with code ZORA for 15% off  Join ⁠⁠⁠Biohacking Menopause⁠⁠⁠ before October 1, 2025 to win a Flexbeam red light therapy device. Or save 10% with code ZORA at https://recharge.health   Join the Hack My Age community on: YouTube: https://youtube.com/@hackmyage Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠  Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠   

Host: Darryl S. Chutka, M.D. Guests: Haraldur Bjarnason, M.D.; and Megha M. Tollefson, M.D. Vascular malformations are anomalies of vessels that can cause a variety of potentially serious health problems depending on their type, location, and size. They may involve arterial, venous or lymphatic vessels. They're often progressive and may enlarge over time. They're best diagnosed with one or more imaging studies and the treatment depends on the type of vascular malformation. Management usually requires a multi-disciplinary approach in order to be most effective. What are the most common types of vascular malformations? What organs are typically involved? What are some of the more serious medical complications they may cause and how should we manage them? The topic for this podcast is “Vascular Malformations” and these are questions I'll be asking my guests, Haraldur Bjarnason, M.D., an interventional and vascular radiologist and Megha M. Tollefson, M.D., a dermatologist, both from the Mayo Clinic. Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

The National Interscholastic Athletic Administrators Association (NIAAA) and AD Insider have partnered up to showcase specific, important topics for this upcoming school year, designed to help your athletic department excel. Join us for multiple episodes of the NIAAA Workshop Series! Episode #1, presented by Concordia University Irvine: When Seconds Count: EAPs in School SportsAED Awareness & Access - Why they're critical, how to keep them accessible, and key use basics.Distribution Programs - Opportunities schools can leverage to improve emergency preparedness.Albuterol Availability - The importance of having quick access for asthma emergencies and current practices in schools.Catastrophic Injury Data - Statistics by sport and position, plus an overview of state-specific laws.Legal Responsibilities - Understanding the obligations and liabilities athletic departments must be aware of. Workshop Host and Featured Experts:Host: Becky Moran, CMAA: Associate Executive Director - National Interscholastic Athletic Administrators Association (NIAAA)Kristen L. Kucera, PhD, MSPH, ATC, LAT - Professor - Exercise and Sport Science, Director - National Center for Catastrophic Sport Injury Research -- University of North Carolina Chapel HillDr. Neha Raukar, MD, MS, FACEP, CAQSM - Physician & Vice Chair at Mayo Clinic, Emergency & Sports Medicine Specialist, 20+ Years of Elite Athlete Care The NIAAA champions the profession of athletic administration through educational opportunities, advocating ethics, developing leaders, and fostering community. Find more information on their website here: niaaa.org.Support the show

This week, Dr. Kahn reports on a new Mayo Clinic study on the relationship between chronic insomnia and accelerated brain aging in a group of study subjects who had advanced brain testing over time. He suggests 20 tips for better sleep and a bonus 21st: cognitive behavioral therapy for insomnia (CBT-I). Additional topics include heart disease remaining the #1 cause of death, TMAO and cognitive impairment, ATTR-cardiomyopathy, childhood blood pressure and future heart disease, niacin and optimal liver health, and the relationship between heart diseases like atrial fibrillation and cognitive decline. Thanks to igennus.com and the discount code DrKahn.  Dr. Kahn will be leading a group Fasting Mimicking Diet starting 10/5/25. Order your PROLON kit (Next Gen) at www.prolonlife.com/drkahn.

Host: Darryl S. Chutka, M.D. Guests: Sam Farres, M.D.; and Ryan A. Meverden, PA-C Thoracic outlet syndromes is a great masquerader and often mistaken for a variety of other health conditions including cervical radiculopathy, carpal tunnel syndrome, rotator cuff injury or even multiple sclerosis. It has several causes which account for the variety of its clinical presentations. Because of this, the diagnosis is commonly delayed or diagnosed incorrectly.  Yet, it's crucial to establish an early and accurate diagnosis as this can prevent potential progression of neurologic damage or in some cases life-threatening vascular complications. It also prevents unnecessary treatments and inappropriate interventions. The topic for this podcast is “Thoracic Outlet Syndrome” and my guests include Ryan Meverden, PA-C, a physician assistant in the Vascular Center at the Rochester campus of the Mayo Clinic and Sam Farres, M.D., Division Chair of Vascular Surgery at the Florida campus of the Mayo Clinic. As we discuss thoracic outlet syndrome, we'll review the variety of presenting symptoms, potential complications, appropriate tests to evaluate patients and effective management strategies. Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

When radiology meets surgery, endometriosis care becomes more precise, personalized, and proactive. In this BackTable OBGYN Brief, host Dr. Mark Hoffman is joined by Dr. Wendaline VanBuren, an associate professor of radiology at Mayo Clinic, and Dr. Tatnai Burnett, a minimally invasive GYN surgeon at Mayo Clinic, to discuss the complexities of diagnosing and managing endometriosis. The discussion covers the roles of advanced imaging techniques like MRI and ultrasound, the importance of pre-surgical planning, and the need for multidisciplinary collaboration. They share their approach to managing symptomatic and asymptomatic patients, the use of hormonal treatments, and the significance of monitoring potential malignant transformations in endometrioma cases. The episode underscores the critical role of imaging in planning effective surgical interventions for patients while highlighting the progression of endometriosis management protocols. TIMESTAMPS 00:00 - Introduction  01:07 - Discussing Endometriosis Management 02:18 - Imaging Techniques and Their Importance 04:24 - Interdisciplinary Collaboration 05:40 - Advanced Imaging Protocols 08:12 - Monitoring and Follow-Up Strategies 08:50 - Concerns About Malignancy 11:04 - Future Directions CHECK OUT THE FULL EPISODE OBGYN Ep. 69 https://www.backtable.com/shows/obgyn/podcasts/69/imaging-protocols-to-guide-endometriosis-treatment

Nick Stageberg is the CEO of Black Swan Real Estate and a former tech entrepreneur who scaled a $13M startup to a $100M exit. He later led 13 engineering teams at Mayo Clinic before building a thriving real estate portfolio with his wife, Elaine. Today Nick leverages his tech-driven approach to give Black Swan a distinct edge in the multifamily industry.   Here's some of the topics we covered:   From Tech Career to Real Estate Freedom How to Turn Setbacks Into Your Greatest Wins Warren Buffet's Surprising Take on D Class Properties Using Real Estate Profits to Create Lasting Impact Must-Know Tips for First-Time Investors How to Land a Mentor Without Spending a Dime Why Real Estate Beats Even the Highest-Paying W2 Job   To find out more about partnering or investing in a multifamily deal: Text Partner to 72345 or email Partner@RodKhleif.com    For more about Rod and his real estate investing journey go to www.rodkhleif.com  

Ready to not only live longer, but to live BETTER?  In this episode, I'm joined by longevity expert Dr. Shah, where we dive into his journey in functional medicine and how he's dedicated his career to educating patients on optimizing their healthspan.  Dr. Shah breaks down the four key pillars of longevity that he uses in his practice to help his patients combat disease and illness to live better, more fulfilling lives.  You'll also learn simple, impactful lifestyle hacks—like eliminating ultra-processed foods, prioritizing self-care strategies, weaving in daily movement, and understanding how to balance stress and recovery.  From understanding crucial biomarkers to track in midlife, to demystifying peptides at a cellular level– Dr. Shah is here to offer science-backed tips that will truly move the needle in helping you feel your best for years to come. Tune in here!  Darshan Shah, MD Dr. Darshan Shah is a health and wellness specialist, board-certified surgeon, published author, and founder of Next Health, the world's first and largest Health Optimization and Longevity clinic. As a Longevity Medicine specialist, he's worked with thousands of patients to help optimize their well-being and extend their healthspan. Dr. Shah earned his medical degree at the age of 21, becoming one of the youngest doctors in the US. He continued his training at the Mayo Clinic, opened medical/surgical centers throughout California, started four other companies in the Health and Wellness space, and has published a book. Dr. Shah's passion is educating people on the topics of adding healthspan to your lifespan. IN THIS EPISODE Dr. Shah's journey to becoming a longevity expert  The importance of finding time in a busy schedule for self-care All about Dr. Shah's functional medicine company, Next Health  Simple ways to add movement to your day  Defining longevity and how to optimize your life span  The 4 key pillars of longevity Key biomarkers of health to track in your 40s and beyond  How your gut microbiome impacts your overall health  What are peptides, and how can they benefit you?  Dr. Shah's top lifestyle tips to truly move the needle for your health  QUOTES “The elimination of ultra-processed food will move the needle more than anything else you could potentially put into your body.” “Now people have access to their data, but step two is having personal responsibility to understand what that data means, why it's important, and following it yourself.”  “There's a balance that our biology needs to live under. It needs to have some stress, and it needs to have time to relax. It needs to have heavy exercise, but it also needs to have just light movement… You have to find where that balance lies in your own system and it's always going to be changing. And you're not going to know this until you check some of these biomarkers.”  RESOURCES MENTIONED

Host: Darryl S. Chutka, M.D. Guest: Stan Henkin, M.D. Peripheral arterial disease is a manifestation of atherosclerosis and becomes more common with advancing age.  In its early stages, it can be quite difficult to diagnose. Although claudication is the most classic symptom, many remain asymptomatic, especially if they have limited ability to ambulate. Although risk factor modification is important in disease management, overall treatment options have been somewhat disappointing. How can we diagnose PAD early and are there advantages in recognizing the disease in an early stage? What are the best ways to establish a diagnosis and what treatment options do we have available?  Our topic for this podcast is “Peripheral Arterial Disease” and these are questions I'll asking my guest, Stan Henkin, M.D., a vascular medicine specialist from the Department of Cardiovascular Medicine at the Mayo Clinic. Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Host: Darryl S. Chutka, M.D. Guest: Ana I. Casanegra, M.D., M.S. For many decades, we really only had one option for providing chronic anticoagulation, warfarin. We learned how to manage the many drug and food interactions, frequently changing the warfarin dose as we tried to keep our patients in therapeutic range. Now we have a variety of choices with the direct-acting oral anticoagulants, or DOAC's. How do the newer agents compare to warfarin in effectiveness? Are they really safer than warfarin? Do they ever require any monitoring? What's the latest on reversing the anticoagulant effect? I'll be discussing these topics and more with my guest, Ana I. Casanegra, M.D., M.S., a vascular medicine specialist at the Mayo Clinic. The topic for this podcast is “How to Choose Your Anticoagulant”. Mayo Clinic Talks: Vascular Medicine Series | Mayo Clinic School of Continuous Professional Development Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts